Prof. Jing CHEN
陳靜教授

Dr. Chen Jing, PhD graduate from the University of Hong Kong, has over a decade of experience in health service research and clinical studies. Before joining the Chinese University of Hong Kong (CUHK), she contributed to various healthcare sectors, including academia, the Food and Health Bureau of HKSAR, and the healthcare industry.

Her research focuses on chronic disease interventions and public health policy implementation. Dr. Chen’s economic evaluations, including smoking cessation for COPD patients, diabetic eye disease screening, AAA screening, and tobacco control policies, have provided pivotal evidence for healthcare advancements, such as the establishment of AAA screening in public hospitals and enhanced tobacco control measures.

Dr. Chen’s research passion extends from health service research to clinical studies, where she collaborates with globally renowned clinicians. Leading multiple clinical studies on HBV, HCV, and liver cancer, she partnered with specialists in Hong Kong and mainland China. Her work on DAAs for personalized HCV treatment and HBV/HCV co-infections has influenced global treatment guidelines, including those of APASL, AASLD, and EASL. Additionally, her economic evaluations have been instrumental in securing DAA approval in China and integrating DAAs into Chinese Health Insurance, benefiting thousands of HCV patients. Her studies have been published in leading journals like Hepatology, Lancet Gastroenterol Hepatol, and Clinical Gastroenterology and Hepatology.

As a trained public health researcher, Dr. Chen, in her Researcher role at FHB in HKSAR, focused on policy research on overseas health systems and best practices, providing evidence for decision-makers on topics including cancer services, primary care, and tobacco control policies. Amid the onset of Covid-19 in late 2019, she immersed herself in commissioned research, involving the creation of dynamic dashboards for local situations, literature reviews on clinical perspectives of Covid-19, and policy reviews for Covid-19 control worldwide. Though intense, this aligns with her professional training and passion.

In her current academic position at CUHK, Dr. Chen actively engages in research centered on developing and evaluating diverse healthcare service models in Hong Kong and China mainland. Her dedication extends to self-sampling and screening initiatives, facilitating early detection and treatment for diseases such as HBV and HPV. Her work underscores her commitment to advancing healthcare research and public health outcomes.